Solara Pharma recalls Nizatidine Capsules from Mylan

Solara Active Pharma Sciences Limited has announced that it has initiated a voluntary recall of three lots of Nizatidine Capsules, USP (150 mg and 300 mg strengths) from Mylan NVs due to detected trace amounts of impurity N-nitrosodimethylamine (NDMA) contained in the Nizatidine API. The company is in the process of collecting corresponding lots of API from Mylan to carry out its internal investigation.